Microbiology Product Finder : Clinical

Sector: Clinical

Test type: SARS-CoV-2/COVID-19 Research

Please use both selection boxes below to find companies that supply products in areas that you are interested:

Tick Boxes below to compare products [Max 3]

Fapon Biotech Neutralizing Antibody Test Solution

Neutralizing antibodies (NAbs) have significant preventive and therapeutic effects. They mainly target the RBD region and can block the binding site of COVID-19 to the ACE2 receptor. COVID-19 NAbs are a low contamination risk and highly specific, which play a crucial role in the research of COVID-19 treatments. Meanwhile,

Recombinant SARS-CoV-2 Spike Protein Receptor Binding Domain [His]

Recombinant SARS-CoV-2 Spike Protein Receptor Binding Domain from HEK293 cells. The antigens can be used for total antibodies detection to SARS-CoV-2 virus in double-antigen sandwich immunoassay. Our antigens are manufactured to the highest quality standards and are performance guaranteed for the applications listed on the detailed datasheets.

Anti-SARS-CoV-2 NP Monoclonal Antibody Pair

Creative Diagnostics team has tested hundreds of anti-nucleocapsid antibody pairs to recommend you the best pair with proven performance in commercially launched rapid antigen COVID-19 assays. Principle: COVID-19 Antigen Rapid Test is a rapid membrane-based lateral flow immunoassay for the qualitative detection of SARS-CoV-2 antigens in human nasopharyngeal

Pseudotyped Luciferase/GFP rSARS-CoV-2 Spike

Pseudotyped Luciferase/GFP rSARS-CoV-2 Spike is used to test the ability of serum, antibodies, and drugs to neutralize the infectivity of SARS-CoV2 spike protein. Pseudovirus display an antigenically-correct spike protein pseudotyped on replication-incompetent virus particles that contain a heterologous lentiviral (HIV) core. Pseudotyped Luciferase/GFP rSARS-CoV-2 Spike is capable of